Bazelet Group

Bazelet Technologies is a cannabis scientific incubator focused on developing innovative enriched-cannabis products. Bazelet Group processes the cannabis grown by four of the eight legal farms in Israel, serving 9,000 patients per month, and is constructing a GMP facility with the capacity for 100,000 patients. Its products include cannabis buds in sealed, barcoded packages; flowers ground in a proprietary method; cannabis cigarettes; cannabis extracts; vaporizer tablets; sustained-release capsules; topicals; and suppositories. Bazelet's operations also include providing secure delivery to homes every month, educating newly licensed users, guiding and offering strain-selection advice to thousands of clients, and operating a call center. The company develops new technologies for vaporizers, veterinary applications, and new delivery methods. Bazelet Group operates as a subsidiary of Jordache Enterprises Inc, Canada, and consists of four cannabis pharmaceutical companies: Bazelet Pharma, Bazelet Nehushtan, Bazelet Technologies, and Bazelet Know-How.

Bazelet Group was founded in 2012 by Meir Ariel (Co-founder & CEO), Aharon (Ari) Eyal, Prof. (Co-founder & CSO).

Bazelet Group operates in Health Tech & Life Sciences, Pharma & Medical Biotechnology, Medical Cannabis, Drug Delivery, with core technologies in Biologicals, Herbals. Target customers: Healthcare & Life Sciences, Life Sciences, Pharmaceuticals, Healthcare, Patients.

Bazelet Group is based in Ha-Histadrut St 2, Nesher, Israel, North District.